Package 46708-586-31

{"route": ["ORAL"], "spl_id": "1ca812f6-6983-4d9a-b08e-a8f7e50054b8", "openfda": {"unii": ["M6Q1EO9TD0"], "rxcui": ["849395"], "spl_set_id": ["48fa07c8-8b95-40d7-a0f5-132577dfb2c8"], "manufacturer_name": ["Alembic Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (46708-586-31)", "package_ndc": "46708-586-31", "marketing_start_date": "20201020"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (46708-586-71)", "package_ndc": "46708-586-71", "marketing_start_date": "20201020"}], "brand_name": "Amantadine", "product_id": "46708-586_1ca812f6-6983-4d9a-b08e-a8f7e50054b8", "dosage_form": "TABLET", "pharm_class": ["Influenza A M2 Protein Inhibitor [EPC]", "M2 Protein Inhibitors [MoA]"], "product_ndc": "46708-586", "generic_name": "Amantadine", "labeler_name": "Alembic Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amantadine", "active_ingredients": [{"name": "AMANTADINE HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA214284", "marketing_category": "ANDA", "marketing_start_date": "20201020", "listing_expiration_date": "20261231"}